Stockreport

MoonLake Secures up to $500 Million in Non-Dilutive Financing from Hercules Capital and Announces a Capital Markets Update on April 29 to Provide Important Clinical Updates [Yahoo! Finance...

MoonLake Immunotherapeutics - Class A Ordinary Shares  (MLTX) 
PDF to shareholders, an attractive cost of capital and low operational and strategic incumbrances, and sets a new standard for the quantum of a nondilutive facility for a de [Read more]